You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 110 No. 9, September 1992 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CORRESPONDENCE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Surgical Options in High-Risk Patients

Eve J. Higginbotham, MD
Ann Arbor, Mich

Arch Ophthalmol. 1992;110(9):1197.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Freedman and Rubin,1 in their article in the October 1991 issue of the ARCHIVES, reported their results with Molteno implants as a treatment for "refractory" glaucoma in black patients. When considering any group of patients with glaucoma, it is important to keep in mind alternative treatments such as filtration surgery with adjunctive use of antimetabolites2 (eg, fluorouracil and mitomycin-C), particularly for adult patients, and a second goniotomy or trabeculotomy in cases of congenital glaucoma. It is unclear from the description of their patients if any of the previously failed 39 trabeculectomies were performed after administration of an antimetabolite. Although the authors did not note as great an incidence of choroidal detachment (among other complications) as did other authors, Molteno implantation is certainly not without its own complications. I am sure the authors will agree that the only way to clearly delineate the best management for . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.